# Constellation Brands’ further £3.1 billion investment into Canopy Growth Corporation

- Link: https://www.directorstalkinterviews.com/constellation-brands-3-1-billion-investment-canopy-growth-corporation/412756942
- Published: 2018-08-20T09:21:41+01:00
- Author: Giles Arbor

**Constellation Brands**, (NYSE:STZ) owned by the same company as Corona beer, Svedka
vodka and Robert Mondavi wine has announced that it plans to spend C$5.1 billion(
£3.1 billion) to raise its stake in Canopy Growth Corporation, a Canadian supplier
of medicinal cannabis products taking its stake from 9.9 per cent to 38 per cent.

> **Geremy Thomas, founder and CEO of Sativa Investments, the UK’s first medicinal
> cannabis investment vehicle, told DirectorsTalk:** “Constellation Brands’ further
> £3.1 billion investment in Canada’s Canopy Growth is an encouraging sign for the
> medicinal cannabis industry, as well-established, successful companies are waking
> up to the fact that this rapidly growing industry is not to be missed out on.
> Sativa continues to invest in well-placed medicinal cannabis companies itself 
> and remains the first UK investment vehicle to offer investors access.”

You can read the full article here: [https://www.thetimes.co.uk/article/fast-growing-weed-is-worth-3bn-toast-th7vkv2ht](https://www.thetimes.co.uk/article/fast-growing-weed-is-worth-3bn-toast-th7vkv2ht)

**Sativa Investments Plc** ([NEX:SATI](https://www.directorstalkinterviews.com/company/goodbody-health/gdby.cn))
seeks to invest in companies which are well-placed to take advantage of the dynamic
regulatory environment surrounding medical Cannabis. Its investment strategy focuses
on production, pharmacology, testing and compliance, R&D commercialisation, and 
sales and marketing. The Directors continue to engage with possible target investments
in their key areas of interest.

Share on:
